Economic Implications of the Use of Basiliximab in Addition to Triple Immunosuppressive Therapy in Renal Allograft Recipients: A UK Perspective

Author： Walters S.J.   Whitfield M.   Akehurst R.L.   Chilcott J.B.  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.21, Iss.2, 2003-01, pp. : 129-138

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Basiliximab: A Review of its Use as Induction Therapy in Renal Transplantation

By Chapman T.M.   Keating G.M.  

Drugs, Vol. 63, Iss. 24, 2003-01 ,pp. : 2803-2835

Adis International

Access to resources Recommend Favorite

Paracetamol disposition in renal allograft recipients

By Martin U.   Temple R.   Venkat-Raman G.   Prescott L.  

European Journal of Clinical Pharmacology, Vol. 57, Iss. 12, 2002-02 ,pp. : 853-856

Springer Publishing Company

Access to resources Recommend Favorite

Basiliximab: economic advantage for renal transplantation in Japan

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 405, 2003-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Cardiovascular complications of immunosuppressive agents in renal transplant recipients

By Olyaei Ali J   deMattos Angelo M   Bennett William M  

Expert Opinion on Drug Safety, Vol. 4, Iss. 1, 2005-01 ,pp. : 29-44

Informa Healthcare

Access to resources Recommend Favorite

Combating Chronic Renal Allograft Dysfunction: Optimal Immunosuppressive Regimens

By Merville Pierre  

Drugs, Vol. 65, Iss. 5, 2005-01 ,pp. : 615-631

Adis International

Access to resources Recommend Favorite